The diagnostic role of pharmacological provocation testing in cardiac electrophysiology

a clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)
Cardiac Channelopathies in the Pediatric Patient: Brugada Syndrome

Patients with ryanodine receptor type 2 (RyR2)-related inherited cardiac syndromes have similar disease manifestations, although important distinctive features exist, which affect diagnosis and treatment.
Rare disease gene association discovery in the 100,000 Genomes Project

Up to 80% of rare disease patients remain undiagnosed after genomic sequencing1, with many probably involving pathogenic variants in yet to be discovered disease–gene associations.
The paper on Diagnostic Approach to Pediatric Brugada Syndrome has been accepted in Heary Rhythm.

The Paper on Diagnostic Approach to Pediatric Brugada Syndrome has been accepted in Heary Rhythm. Our deep gratitude to all participating centers. Link to the article: https://www.heartrhythmjournal.com/article/S1547-5271(24)00217-0/abstract